Dr. David Spigel: What are the most promising targeted therapy approaches in lung cancer for the next few years?

GRACE Videos and Articles

Dr. David Spigel from Sarah Cannon Cancer Center offers his perspective on the agents he feels most likely to become clinical tools against lung cancer over the next few years.



Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation